Terms: = Colorectal cancer AND EP300, ENSG00000100393, 2033, RP1-85F18_1, p300
172 results:
1. Integrative network analysis of transcriptomics data reveals potential prognostic biomarkers for colorectal cancer.
Mahajan M; Sarkar A; Mondal S
Cancer Med; 2024 Jun; 13(11):e7391. PubMed ID: 38872418
[TBL] [Abstract] [Full Text] [Related]
2. Beyond standard treatment: A qualitative descriptive study of cancer patients' perceptions of hypnotherapy in cancer care.
Szmaglinska M; Andrew L; Massey D; Kirk D
Complement Ther Clin Pract; 2024 Aug; 56():101861. PubMed ID: 38820657
[TBL] [Abstract] [Full Text] [Related]
3. Acetylation of ELMO1 correlates with Rac1 activity and colorectal cancer progress.
Li C; Yi J; Jie H; Liu Z; Li S; Zeng Z; Zhou Y
Exp Cell Res; 2024 Jun; 439(1):114068. PubMed ID: 38750717
[TBL] [Abstract] [Full Text] [Related]
4. Chemical Genetics in
Abraham E; Athapaththu AMGK; Atanasova KR; Chen QY; Corcoran TJ; Piloto J; Wu CW; Ratnayake R; Luesch H; Choe KP
ACS Chem Biol; 2024 May; 19(5):1180-1193. PubMed ID: 38652683
[No Abstract] [Full Text] [Related]
5. Factors associated with sexual dysfunction in patients with colorectal cancer in Iran: a cross-sectional study.
Dahouri A; Sahebihagh MH; Gilani N
Sci Rep; 2024 Feb; 14(1):4915. PubMed ID: 38418573
[TBL] [Abstract] [Full Text] [Related]
6. Musashi-2 potentiates colorectal cancer immune infiltration by regulating the post-translational modifications of HMGB1 to promote DCs maturation and migration.
Meng X; Na R; Peng X; Li H; Ouyang W; Zhou W; You X; Li Y; Pu X; Zhang K; Xia J; Wang J; Tang H; Zhuang G; Peng Z
Cell Commun Signal; 2024 Feb; 22(1):117. PubMed ID: 38347600
[TBL] [Abstract] [Full Text] [Related]
7. Degradative autophagy regulates the homeostasis of miRnas to control cancer development.
Wu SY; Chu CA; Lan SH; Liu HS
Autophagy; 2024 Jun; 20(6):1444-1446. PubMed ID: 38294001
[TBL] [Abstract] [Full Text] [Related]
8. [Analysis of clinicopathological features and prognosis of sporadic synchronous multiple primary colorectal cancers].
Qin ZF; Xu GH; Zhou SQ; Zheng PW; Zhu YP; Ju HX; Li DC; Ma DN
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Dec; 26(12):1171-1178. PubMed ID: 38110279
[No Abstract] [Full Text] [Related]
9. Inhibition of CREB Binding and Function with a Dual-Targeting Ligand.
Liu Y; Joy ST; Henley MJ; Croskey A; Yates JA; Merajver SD; Mapp AK
Biochemistry; 2024 Jan; 63(1):1-8. PubMed ID: 38086054
[TBL] [Abstract] [Full Text] [Related]
10. MiR-26a-5p exerts its influence by targeting ep300, a molecule known for its role in activating the PI3K/AKT/mTOR signaling pathway in CD8+tumor-infiltrating lymphocytes of colorectal cancer.
Wang C; Lin H; Zhao W; Liang Y; Chen Y; Wang C
Cell Mol Biol (Noisy-le-grand); 2023 Nov; 69(12):232-241. PubMed ID: 38063089
[TBL] [Abstract] [Full Text] [Related]
11. Transcriptome and proteome analysis reveals the anti-cancer properties of Hypnea musciformis marine macroalga extract in liver and intestinal cancer cells.
Begolli R; Chatziangelou M; Samiotaki M; Goutas A; Barda S; Goutzourelas N; Kevrekidis DP; Malea P; Trachana V; Liu M; Lin X; Kollatos N; Stagos D; Giakountis A
Hum Genomics; 2023 Jul; 17(1):71. PubMed ID: 37525271
[TBL] [Abstract] [Full Text] [Related]
12. p300 increases CSNK2A1 expression which accelerates colorectal cancer progression through activation of the PI3K-AKT-mTOR axis.
Liu J
Exp Cell Res; 2023 Sep; 430(1):113694. PubMed ID: 37391010
[TBL] [Abstract] [Full Text] [Related]
13. Glutamate dehydrogenase1 supports HIF-1α stability to promote colorectal tumorigenesis under hypoxia.
Hu K; Ding Y; Zhu H; Jing X; He W; Yu H; Wang X
EMBO J; 2023 Jun; 42(12):e112675. PubMed ID: 37092319
[TBL] [Abstract] [Full Text] [Related]
14. Imatinib blocks tyrosine phosphorylation of Smad4 and restores TGF-β growth-suppressive signaling in BCR-ABL1-positive leukemia.
Wang L; Gu S; Chen F; Yu Y; Cao J; Li X; Gao C; Chen Y; Yuan S; Liu X; Qin J; Zhao B; Xu P; Liang T; Tong H; Lin X; Feng XH
Signal Transduct Target Ther; 2023 Mar; 8(1):120. PubMed ID: 36959211
[TBL] [Abstract] [Full Text] [Related]
15. Bacterial infection promotes tumorigenesis of colorectal cancer via regulating CDC42 acetylation.
Wang DN; Ni JJ; Li JH; Gao YQ; Ni FJ; Zhang ZZ; Fang JY; Lu J; Yao YF
PLoS Pathog; 2023 Feb; 19(2):e1011189. PubMed ID: 36812247
[TBL] [Abstract] [Full Text] [Related]
16. Targeting KRAS-mutant stomach/colorectal tumors by disrupting the ERK2-p53 complex.
Wang X; Xie Q; Ji Y; Yang J; Shen J; Peng F; Zhang Y; Jiang F; Kong X; Ma W; Liu D; Zheng L; Qing C; Lang JY
Cell Rep; 2023 Jan; 42(1):111972. PubMed ID: 36641751
[TBL] [Abstract] [Full Text] [Related]
17. Racial/Ethnic and Sex Differences in Somatic cancer Gene Mutations among Patients with Early-Onset colorectal cancer.
Holowatyj AN; Wen W; Gibbs T; Seagle HM; Keller SR; Edwards DRV; Washington MK; Eng C; Perea J; Zheng W; Guo X
Cancer Discov; 2023 Mar; 13(3):570-579. PubMed ID: 36520636
[TBL] [Abstract] [Full Text] [Related]
18. CXCL1 promotes colon cancer progression through activation of NF-κB/p300 signaling pathway.
Zhuo C; Ruan Q; Zhao X; Shen Y; Lin R
Biol Direct; 2022 Nov; 17(1):34. PubMed ID: 36434686
[TBL] [Abstract] [Full Text] [Related]
19. Systematic Analysis of CXC Chemokine-Vascular Endothelial Growth Factor A Network in Colonic Adenocarcinoma from the Perspective of Angiogenesis.
Situ Y; Lu X; Cui Y; Xu Q; Deng L; Lin H; Shao Z; Chen J
Biomed Res Int; 2022; 2022():5137301. PubMed ID: 36246978
[TBL] [Abstract] [Full Text] [Related]
20. A genetic map of the chromatin regulators to drug response in cancer cells.
Chen B; Li P; Liu M; Liu K; Zou M; Geng Y; Zhuang S; Xu H; Wang L; Chen T; Li Y; Zhao Z; Qi L; Gu Y
J Transl Med; 2022 Sep; 20(1):438. PubMed ID: 36180906
[TBL] [Abstract] [Full Text] [Related]
[Next]
